New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
05:58 EDTBAXSBaxano Surgical pullback brings attractive risk/reward, says Brean Capital
Brean Capital believes the recent pullback in shares of Baxano Surgical provides a compelling risk/reward profile relative to its $4 price target. Brean thinks that if Baxano can prove itself over the next two years, it is likely to be taken out. The firm reiterates a Buy rating on the name.
News For BAXS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for BAXS

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use